Service de Réanimation, CH de St BRIEUC, 10, rue Marcel Proust 22000 Saint-Brieuc, France.
Service de Microbiologie, CH de St BRIEUC, 10, rue marcel Proust 22000 Saint-Brieuc, France.
Infect Dis Now. 2023 Apr;53(3):104666. doi: 10.1016/j.idnow.2023.104666. Epub 2023 Feb 2.
Decontamination regimen decreases acquired infection (ICU-AI) incidence but has remained controversial, mostly because it contains a course of intravenous antibiotic. Multiple-site decontamination (MSD), which does not include systemic antibiotics, has been less widely studied but is associated with lower risks of ventilator-associated pneumonia (VAP), bloodstream infection (BSI) and multidrug resistant micro-organism (MDRO) acquisition. We aimed to confirm these favorable outcomes.
A prospective pre/post-observational study was conducted in 5 ICUs in western France. Among them, 4 implemented MSD, whereas the fifth applied standard care (SC) throughout the study period. Patients who required intubation were eligible for study and divided into two groups: the MSD group if they were admitted to an ICU that already implemented MSD, or the SC group. The primary objective was to measure ICU-AI incidence.
Close to 1400 (1346) patients were available for analysis (334 in the MSD and 1012 patients in the SC group). In a multivariable Poisson regression model, MSD was independently associated with decreased incidence of ICU-AI (IRR = 0.33; 95 %CI [0.18-0.60] p < 0.001). Non-parsimonious propensity-score matching resulted in 334 patient-pairs with well-balanced baseline characteristics. There was a lower incidence of ICU-AI(6.3 % vs 20.7 % p < 0.001), VAP (3.6 % vs 16.2 % p < 0.001) and BSI (3.0 % vs 7.2 % p = 0.029) in the MSD group as compared with the SC group. Five (1.5 %) and 11 (3.3 %) patients respectively acquired MDRO (p = 0.206).
MSD is associated with decreased risk of ICU-AI, VAP and BSI, with no increase in MDRO acquisition.
去污方案可降低 ICU 获得性感染(ICU-AI)的发生率,但仍存在争议,主要是因为它包含一个疗程的静脉用抗生素。多部位去污(MSD)不包括全身抗生素,研究较少,但与呼吸机相关性肺炎(VAP)、血流感染(BSI)和多重耐药微生物(MDRO)的风险降低相关。我们旨在证实这些有利的结果。
在法国西部的 5 个 ICU 进行了前瞻性前后观察性研究。其中 4 个实施了 MSD,而第 5 个在整个研究期间实施了标准护理(SC)。需要插管的患者符合研究条件,并分为两组:如果他们入住已经实施 MSD 的 ICU,则为 MSD 组,如果他们入住 SC 组。主要目的是测量 ICU-AI 的发生率。
近 1400(1346)名患者可用于分析(MSD 组 334 名,SC 组 1012 名)。在多变量泊松回归模型中,MSD 与 ICU-AI 发生率降低独立相关(IRR=0.33;95%CI [0.18-0.60] p<0.001)。非简约倾向评分匹配产生了 334 对具有良好基线特征的患者对。MSD 组 ICU-AI(6.3% vs 20.7% p<0.001)、VAP(3.6% vs 16.2% p<0.001)和 BSI(3.0% vs 7.2% p=0.029)的发生率较低。MSD 组分别有 5(1.5%)和 11(3.3%)名患者获得 MDRO(p=0.206)。
MSD 与 ICU-AI、VAP 和 BSI 的风险降低相关,而 MDRO 的获得没有增加。